Health

Generic Prostate Cancer Therapy Nears EU Approval

TribeNews
By TribeNews 3 Views Add a Comment
0 Min Read
Generic Prostate Cancer Therapy Nears EU Approval

At its November 2025 meeting, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use recommended granting marketing authorization in the EU for Enzalutamide Accordpharma (Accord Healthcare) for the treatment of prostate cancer.  Enzalutamide Accordpharma is a generic and hybrid of Xtandi (enzalutamide, Astellas Pharma…

Leave a Comment
Ads Blocker Image Powered by Code Help Pro

Ads Blocker Detected & This Is Prohibited!!!

We have detected that you are using extensions to block ads and you are also not using our official app. Your Account Have been Flagged and reported, pending de-activation & All your earning will be wiped out. Please turn off the software to continue

You cannot copy content of this app